Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 Duke Medicine Cir
Durham, NC 27710Phone+1 888-275-3853- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
- Duke University School of MedicineClass of 1992
- Duke UniversityB.S., 1988
Certifications & Licensure
- NC State Medical License 2003 - 2024
- FL State Medical License 2014 - 2018
- MA State Medical License 1998 - 2005
- MD State Medical License 1995 - 1998
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- George P. Canellos Award for Excellence In Clinical Research 2003
- Eugene P. Shonfeld Award Kidney Cancer Association, 2002
- Join now to see all
Clinical Trials
- RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer Start of enrollment: 2005 Aug 01
- Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001 Start of enrollment: 2007 Jan 01
- Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy Start of enrollment: 2006 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.Park, J., Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McD...> ;Clinical Cancer Research. 2024 Mar 15
- Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.Daniel E Spratt, Daniel J George, Neal D Shore, Michael S Cookson, Daniel R Saltzstein, Ronald Tutrone, Alberto Bossi, Bruce A Brown, Sophia Lu, Mark Fallick, Sarah Ha...> ;JAMA Oncology. 2024 Mar 7
- Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with ...Andrew B Nixon, Yingmiao Liu, Qian Yang, Bin Luo, Mark D Starr, John C Brady, Wm Kevin Kelly, Himisha Beltran, Michael J Morris, Daniel J George, Andrew J Armstrong, S...> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 12
- Join now to see all
Journal Articles
- Survuval Outcomes of Sipuleucel-T Phase 3 Studies: Impact of Control Arm Cross-over to Salvage ImmunotherapyGeorge DJ, Nabhan C, DeVries T, Whitmore JB, Gomella LG, Cancer Immunol Res, 1/5/2016
- Clinical Trial Participants with Metastatic Renal Cell Carcinoma Differ From Patients treated in Real-World PracticeMitchell AP, Harrison MR, Walker MS, George DJ, Abernethy AP, Hersch BR, J Oncol Pract, 1/1/2016
- Trial Design and objectives for castration-resistant prostate cancer: Updated recommendations from the prostate cancer clinical trials working group 3Scher HI, Morris MJ, Stadler WM, Higano C, Basch E, Fizazi K, Antonarakis ES, Beer TM, Carducci MA, Chi KN, Corn PG, de Bono JS, Dreicer R, George DJ, Heath EI, Hussai..., J Clin Oncol, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancerArmstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, Embree E, Morris K, Winters C, Jaffe T, Fleming MT, George DJ, Journal of Clinical Oncology, Genitourinary Cancers Symposium, 1/1/2013
- Isolation of circulating tumor cells using a novel EMT-based capture methodBitting RL, Boominathan R, Rao C, Embree E, George DJ, Connelly MC, Kemeny G, Garcia-Blanco M, Armstrong AJ, Journal of Clinical Oncology, 1/1/2012
- Subsequent treatment with APC8015F and its effect on survival in the control arm of phase III sipuleucel-t studiesGeorge DJ, Nabhan C, Gomella LG, Whitmore JB, Frohlich MW, Genitourinary Cancers Symposium, General Poster Session B: Prostate Cancer, Journal of Clinical Oncology, 1/1/2011
- Join now to see all
Lectures
- Prostate, Colon and smoking cessationDurham, NC - 1/1/2016
- Extending Survival in Kidney Cancer: The New RealityChicago, IL - 1/1/2016
- Duke Cancer Institute’s approach to prostate cancer screening and implementation of an active surveillance program: Doing the right thing for our patientsDurham, NC - 1/1/2015
- Join now to see all
Other
- Immunotherapy of renal cell carcinomaGeorge D, Jonasch E
http://www.uptodate.com/contents/immunotherapy-of-renal-cell-carcinoma
UpToDate, Wolters Kluwer Health - 2012-09-17
Press Mentions
- Survival Edge Found Among Black US Veterans with mCRPCFebruary 17th, 2023
- Metastatic Prostate Cancer: Investigators Ponder New Path to Improve SurvivalSeptember 30th, 2022
- ASCO GU 2022: Key Takeaways in Prostate Cancer ImagingApril 1st, 2022
- Join now to see all
Hospital Affiliations
- Duke Raleigh HospitalRaleigh, North Carolina
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: